Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
20. March 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16309
Articles 1 - 20 / 326173
Comparative efficacy and safety of the trastuzumab biosimilar HLX02 versus originator trastuzumab in the neoadjuvant THP-EC regimen for early-stage HER2-positive breast cancer: a real-world study.
Expert Opin Biol Ther
Wang M, Sheng X, Zhu Q, Shen D, Li J, Tao X, Wang J, Zha X.
PMID: 41860104 [PubMed - as supplied by publisher]
Mechanistic insights into the roles of astragalosides and Astragalus polysaccharides in gynecological and breast cancers (Review).
Oncol Rep
Liu R, Lin Z, Li Y, Ci Y, Guo Z, Xu Z.
PMID: 41860034 [PubMed - indexed for MEDLINE]
Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000-14 (CONCORD-3).
Jpn J Clin Oncol
Watanabe K, Di Carlo V, Sugiyama H, Nakamura S, Chei CL, Narimatsu H, Matz M, Oki I, Shibata A, Nakata K, Kajiwara Saito M, Matsuzaka M, Nishio M, Oze I, Tanaka R, Gatellier L, Yoshida I, Ito H, Teramoto N, Yamashita N, Kaizaki Y, Moki F, Kurosawa K, Nemoto Y, Kanemura S, Miyashiro I, Mori D, Fujita S, Matsuda T, Coleman MP, Allemani C.
PMID: 41859890 [PubMed - indexed for MEDLINE]
Feasibility and Outcomes of a Robotic Retroperitoneal Approach to Para-Aortic Lymphadenectomy in Intermediate- and High-Risk Endometrial Cancer: A Prospective Study.
Int J Med Robot
Kubo-Kaneda M, Yoshida K, Kotaka S, Okumura A, Mastumoto T, Okamoto K, Kondo E.
PMID: 41859856 [PubMed - indexed for MEDLINE]
Attitudes of Breast Cancer Chemotherapy Patients and Nurses Toward Acceptance of AI Psychological Nursing: A Qualitative Study.
J Multidiscip Healthc
Chu T, Chen X, Zhang Q, Zhou H, Chen L, Jiang K.
PMID: 41859537 [PubMed]
A low-cost color sensor device for rapid detection of high-grade serous ovarian carcinoma (HGSOC).
Oncoscience
Iqbal F.
PMID: 41859197 [PubMed]
Critical role of reproductive tract microbiota and derived metabolites in inflammation, tumor immunity, and tumorigenesis of gynecological cancers: a narrative review.
Front Immunol
Chen H, Lou G, Meng F, Zhang Y, Kuang H, Yang D.
PMID: 41859112 [PubMed - indexed for MEDLINE]
Locoregional recurrence of triple-negative breast cancer with low tumor-infiltrating lymphocytes: a case report.
Pan Afr Med J
Khadiri K, Khadrouf Z, Sadry M, Essalihi A, Bouchra O, Benchekroun MT, Karkouri M.
PMID: 41858972 [PubMed - indexed for MEDLINE]
JAK/STAT-mediated regulation of PD-L1 expression in breast cancer: Molecular mechanisms and implications for immunotherapy.
iScience
Sang H, Zhao X.
PMID: 41858895 [PubMed]
Effectiveness and safety of auricular therapy for polycystic ovary syndrome: a systematic review and meta-analysis.
Front Endocrinol (Lausanne)
Li X, Xu S, Xie L, Kuang H, Liu J, Li Y.
PMID: 41858851 [PubMed - indexed for MEDLINE]
PSYCHOSOCIAL DISTRESS, BODY IMAGE PERCEPTION, AND COPING MECHANISMS AMONG BREAST CANCER PATIENTS: A CROSS-SECTIONAL STUDY AT A TERTIARY HEALTH FACILITY IN SUB-SAHARAN AFRICA.
Ann Ib Postgrad Med
Sarimiye FO, Oladeji AA.
PMID: 41858821 [PubMed]
Combinatorial Anti-Mitotic Activity of Loratadine/5-Fluorouracil Loaded Zein Tannic Acid Nanoparticles in Breast Cancer Therapy: In silico, in vitro and Cell Studies.
Int J Nanomedicine
Hamdi M, Al-Tabakha MM, Ali IH, Khalil IA.
PMID: 41858579 [PubMed - indexed for MEDLINE]
Exosomes for Polycystic Ovary Syndrome Treatment: Mechanisms and Therapeutic Potential.
Int J Nanomedicine
Liu P, Sha Y, Yang H, Liu T.
PMID: 41858578 [PubMed - indexed for MEDLINE]
Extracellular Vesicles as Emerging Drug Delivery Platforms in Triple-Negative Breast Cancer: A Systematic Review.
Int J Nanomedicine
Tian J, Chin YZ, Ng MH, Pang KL, Law JX.
PMID: 41858569 [PubMed - indexed for MEDLINE]
Recent Advances in Antibody-Drug Conjugates and Immunotherapy Combinations for Treatment of Triple-Negative Breast Cancer.
Breast Cancer (Dove Med Press)
Chen H, Lu W, Zhou Y, Guo X, Wu S, Chen Y.
PMID: 41858531 [PubMed]
Prognostic Significance of the CRP-Albumin-Lymphocyte Index (CALLY) in Triple Negative Breast Cancer Patients: A Real-World Retrospective Study.
Breast Cancer (Dove Med Press)
Liu Y, Zhang F, Guo C, Li Q.
PMID: 41858530 [PubMed]
Emerging Targeted and Multimodal Therapeutic Strategies in Breast Cancer: A Comprehensive Review.
Breast Cancer (Dove Med Press)
Wu W, He Y, Zhang C.
PMID: 41858526 [PubMed]
Long-term effects of using pegylated recombinant human granulocyte colony-stimulating factor following chemotherapy: A real-world study on patients with ovarian cancer.
Oncol Lett
Zhang W, Tang N, Wang Y, Feng T, Yong M, Zeng Y.
PMID: 41858378 [PubMed]
Evaluation of the accuracy of cone-beam CT-based dose calculation for target volumes and organs at risk in left-sided breast cancer radiotherapy.
Front Oncol
Hou X, Bai Z, Jin X, Dai E, Jiang Y, Ma J, Li J.
PMID: 41858368 [PubMed]
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review.
Front Oncol
Lommer C, Schroeder L, Amato C, Dhakal K, Kotian C, Quiroga D, Paskett ED, Fu MR, McAlearney AS, Collins S, King TA, McLaughlin SA, Myers SP.
PMID: 41858365 [PubMed]
Articles 1 - 20 / 326173
Page 1 of 16309
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy